The FDA has approved satralizumab (Enspryng) for neuromyelitis optica spectrum disorder (NMOSD), making Genentech’s drug the first and only injectable treatment for the rare disease. Source: AAO
This study investigates the characteristics of patients undergoing anti-VEGF injections for residual or recurrent diabetic macular edema (DME) after receiving a fluocinolone acetonide implant. Source: AAO
This week, Regeneron shows off their second-quarter financial report, researchers discover a new treatment target for retinal diseases and OCT scans reveal an unexpected cause of a patient’s declining vision. Source: AAO
The FDA has received case reports of toxic anterior segment syndrome (TASS) following intraocular administration of compounded drugs using moxifloxacin as a bulk drug substance. Source: AAO
This retrospective study assessed the effectiveness of intracameral phenylephrine-ketorolac during cataract surgery versus postoperative topical steroids. Source: AAO
This study assessed the relationship between retinal vessel density on OCT angiography and visual field sensitivity loss in highly myopic eyes with primary open-angle glaucoma (POAG). Source: AAO
The American Academy of Ophthalmology is seeking an editor-in chief for Ophthalmology Science, the first open access journal in the Ophthalmology journal family. Source: AAO
Investigators retrospectively reviewed patients who sustained facial injury after riding an electric scooter. Source: AAO
This week, AMD is linked to greater COVID mortality, Bausch Health unveils plans to divest Bausch + Lomb and jawfish show off their pretty—and protective—silver eyes. Source: AAO
Eyenuk has gained regulatory clearance to market its autonomous AI system, EyeArt, for detecting diabetic retinopathy. Source: AAO
Tel: 518-580-0553
Get Directions »
Tel: 518-580-0553
Get Directions »
Tel: +1 (518) 580-0553
Get Directions »